Glory Health Industry Limited (2329.HK)
HKD 0.09
(-10.1%)
HKD 0.09
(-10.1%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 512.92 Million | 606.31 Million | 4.34 Billion | 4.93 Billion | 5.5 Billion | 742.26 Million |
| Net Income | -678.62 Million | -912.78 Million | 228.33 Million | 98.74 Million | 859.76 Million | 1 Billion |
| Depreciation & Amortization | 83.49 Million | 96.26 Million | 92.67 Million | 88.01 Million | 82.84 Million | 72.28 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 840.7 Million | 3.37 Billion | 6.55 Billion | -5.18 Million | 103 Million | -356.08 Million |
| Other non-cash items | 499.84 Million | -1.94 Billion | -2.52 Billion | 4.75 Billion | 4.46 Billion | 17.28 Million |
| Investing Cash Flow | 58.95 Million | -305.41 Million | 184.15 Million | -2.77 Billion | -2.21 Billion | 2.5 Billion |
| Investments in PPE | -60.81 Million | -192.84 Million | -279.53 Million | -272.62 Million | -129.1 Million | -436.7 Million |
| Acquisitions | 195.88 Million | -36.78 Million | 307.1 Million | -364.37 Million | -200.16 Million | 697.53 Million |
| Investment purchases | - | - | - | -37.4 Million | -64 Million | -287.03 Million |
| Sales/Maturities of investments | - | - | - | 37.23 Million | 198.6 Million | 287.14 Million |
| Other Investing Activities | 1.87 Million | -75.78 Million | 156.58 Million | -2.14 Billion | -2.02 Billion | 2.24 Billion |
| Financing Cash Flow | -627.4 Million | -630.9 Million | -5.65 Billion | -1.11 Billion | -3.78 Billion | -3.8 Billion |
| Debt repayment | -177.76 Million | -691.51 Million | -4.27 Billion | -11.85 Billion | -16.9 Billion | -18.38 Billion |
| Dividends payments | - | - | - | -150 Million | -444.69 Million | -95.81 Million |
| Common Stock Repurchased | - | - | - | - | - | 18.37 Billion |
| Common Stock Issuance | - | - | - | - | - | 1.24 Million |
| Other Financing Activities | 26.98 Million | 60.61 Million | -1.38 Billion | 10.88 Billion | 13.56 Billion | -3.71 Billion |
| Accounts receivables | -488.38 Million | 512.95 Million | 142.79 Million | -485.19 Million | -44.79 Million | -356.08 Million |
| Accounts payables | - | -5.5 Million | -145.44 Million | -753.09 Million | 559.96 Million | - |
| Inventory | 2.62 Billion | 2.85 Billion | 6.41 Billion | 480.01 Million | 147.79 Million | -6000.00 |
| Other working capital | -3.69 Million | 5.5 Million | 145.44 Million | 753.09 Million | -559.96 Million | -2.09 Billion |
| Cash at beginning of period | 130.22 Million | 460.22 Million | 1.58 Billion | 536.92 Million | 1.03 Billion | 1.59 Billion |
| Cash at end of period | 74.69 Million | 130.22 Million | 460.22 Million | 1.58 Billion | 536.92 Million | 1.03 Billion |
| Capital Expenditure | -60.81 Million | -192.84 Million | -279.53 Million | -272.62 Million | -129.1 Million | -436.7 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -55.52 Million | -330 Million | -1.12 Billion | 1.04 Billion | -493.21 Million | -561.36 Million |
| Free Cash Flow | 452.11 Million | 413.46 Million | 4.06 Billion | 4.66 Billion | 5.37 Billion | 305.56 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -297.09 Million | -678.62 Million | -266.87 Million | -912.78 Million | -230.29 Million | -682.48 Million |
| Depreciation & Amortization | 47.41 Million | 83.49 Million | 36.07 Million | 96.26 Million | 61.48 Million | 34.78 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 2.12 Billion | 840.7 Million | - | 3.37 Billion | 3.37 Billion | - |
| Other non-cash items | -1.82 Billion | 499.84 Million | 692.88 Million | -1.94 Billion | -3.63 Billion | 1.67 Billion |
| Investing Cash Flow | -17.26 Million | 58.95 Million | 76.22 Million | -305.41 Million | 846.17 Million | -1.15 Billion |
| Investments in PPE | -60.56 Million | -60.81 Million | -243 Thousand | -192.84 Million | -113.72 Million | -79.12 Million |
| Acquisitions | - | 195.88 Million | - | -36.78 Million | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 43.3 Million | 1.87 Million | 76.46 Million | -75.78 Million | 959.9 Million | -1.07 Billion |
| Financing Cash Flow | -31.37 Million | -627.4 Million | -596.03 Million | -630.9 Million | -598.89 Million | -32 Million |
| Debt repayment | - | -177.76 Million | -134.9 Million | -691.51 Million | - | -84.8 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -31.37 Million | 26.98 Million | -461.12 Million | 60.61 Million | -598.89 Million | 52.79 Million |
| Accounts receivables | -488.38 Million | -488.38 Million | - | 512.95 Million | 512.95 Million | - |
| Accounts payables | - | - | - | -5.5 Million | - | - |
| Inventory | 2.62 Billion | 2.62 Billion | - | 2.85 Billion | 2.85 Billion | - |
| Other working capital | -3.69 Million | -3.69 Million | - | 5.5 Million | 5.5 Million | - |
| Cash at beginning of period | 72.49 Million | 130.22 Million | - | 460.22 Million | 305.48 Million | - |
| Cash at end of period | 72.49 Million | 74.69 Million | 72.49 Million | 130.22 Million | - | 305.48 Million |
| Capital Expenditure | -60.56 Million | -60.81 Million | -243 Thousand | -192.84 Million | -113.72 Million | -79.12 Million |
| Effect of forex changes on cash | - | - | 130.22 Million | - | -130.22 Million | 460.22 Million |
| Net cash flow / Change in cash | - | -55.52 Million | 72.49 Million | -330 Million | -305.48 Million | 305.48 Million |
| Free Cash Flow | -9.72 Million | 452.11 Million | 461.84 Million | 413.46 Million | -536.27 Million | 949.73 Million |
1416
CHVKY
002379
CAUUF
LMAT
KENDR